+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2020

  • ID: 5189460
  • Report
  • October 2020
  • Region: Global
  • 140 pages
  • GlobalData

FEATURED COMPANIES

  • Aespira Ltd.
  • Creare LLC
  • Iconovo AB
  • Monash University
  • OtiTopic LLC
  • Sandoz International GmbH
  • MORE
Summary

The publisher's Medical Devices sector report, “Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2020“. Dry powder inhaler devices deliver medication to the lungs in the form of a dry powder.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Dry Powder Inhaler Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Dry Powder Inhaler Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Dry Powder Inhaler Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aespira Ltd.
  • Creare LLC
  • Iconovo AB
  • Monash University
  • OtiTopic LLC
  • Sandoz International GmbH
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Dry Powder Inhaler Devices Overview

3 Products under Development
3.1 Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
3.2 Dry Powder Inhaler Devices - Pipeline Products by Territory
3.3 Dry Powder Inhaler Devices - Pipeline Products by Regulatory Path
3.4 Dry Powder Inhaler Devices - Pipeline Products by Estimated Approval Date
3.5 Dry Powder Inhaler Devices - Ongoing Clinical Trials

4 Dry Powder Inhaler Devices - Pipeline Products under Development by Companies
4.1 Dry Powder Inhaler Devices Companies - Pipeline Products by Stage of Development
4.2 Dry Powder Inhaler Devices - Pipeline Products by Stage of Development

5 Dry Powder Inhaler Devices Companies and Product Overview
5.1 Adamis Pharmaceuticals Corp Company Overview
5.1.1 Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
5.2 Advent Pharmaceuticals Pty Ltd Company Overview
5.2.1 Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.3 Aespira Ltd. Company Overview
5.3.1 Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.4 AKELA Pharma Inc. (Inactive) Company Overview
5.4.1 AKELA Pharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.5 AstraZeneca Plc Company Overview
5.5.1 AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Bayer AG Company Overview
5.6.1 Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
5.7 Boehringer Ingelheim International GmbH Company Overview
5.7.1 Boehringer Ingelheim International GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.8 Circassia Group Plc Company Overview
5.8.1 Circassia Group Plc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Creare LLC Company Overview
5.9.1 Creare LLC Pipeline Products & Ongoing Clinical Trials Overview
5.10 Eli Lilly and Co Company Overview
5.10.1 Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
5.11 GlaxoSmithKline Plc Company Overview
5.11.1 GlaxoSmithKline Plc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Hovione Technology Ltd Company Overview
5.12.1 Hovione Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.13 Iconovo AB Company Overview
5.13.1 Iconovo AB Pipeline Products & Ongoing Clinical Trials Overview
5.14 Liquidia Technologies Inc Company Overview
5.14.1 Liquidia Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Lupin Pharmaceuticals Inc Company Overview
5.15.1 Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 MannKind Corp Company Overview
5.16.1 MannKind Corp Pipeline Products & Ongoing Clinical Trials Overview
5.17 Monash University Company Overview
5.17.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview
5.18 Nektar Therapeutics Company Overview
5.18.1 Nektar Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
5.19 Ology Bioservices Inc Company Overview
5.19.1 Ology Bioservices Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 OPKO Health Inc Company Overview
5.20.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 OtiTopic LLC Company Overview
5.21.1 OtiTopic LLC Pipeline Products & Ongoing Clinical Trials Overview
5.22 Pharmaxis Ltd Company Overview
5.22.1 Pharmaxis Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.23 Quench Medical Inc Company Overview
5.23.1 Quench Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.24 Respira Therapeutics Inc Company Overview
5.24.1 Respira Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.25 Sandoz International GmbH Company Overview
5.25.1 Sandoz International GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.26 Sheffield Hallam University Company Overview
5.26.1 Sheffield Hallam University Pipeline Products & Ongoing Clinical Trials Overview
5.27 Spyryx Biosciences Inc Company Overview
5.27.1 Spyryx Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.28 Sun Pharma Advanced Research Company Ltd Company Overview
5.28.1 Sun Pharma Advanced Research Company Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.29 University of Kansas Company Overview
5.29.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
5.30 University of Sydney Company Overview
5.30.1 University of Sydney Pipeline Products & Ongoing Clinical Trials Overview
5.31 University of Texas Medical Branch at Galveston Company Overview
5.31.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
5.32 Vectura Group Plc Company Overview
5.32.1 Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview
5.33 Verona Pharma Plc Company Overview
5.33.1 Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
5.34 Virginia Commonwealth University Company Overview
5.34.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview

6 Dry Powder Inhaler Devices- Recent Developments

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
Table 2: Dry Powder Inhaler Devices - Pipeline Products by Territory
Table 3: Dry Powder Inhaler Devices - Pipeline Products by Regulatory Path
Table 4: Dry Powder Inhaler Devices - Pipeline Products by Estimated Approval Date
Table 5: Dry Powder Inhaler Devices - Ongoing Clinical Trials
Table 6: Dry Powder Inhaler Devices Companies - Pipeline Products by Stage of Development
Table 7: Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
Table 8: Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Taper DPI - Product Status
Table 10: Taper DPI - Product Description
Table 11: Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 12: g60 Dry Powder Inhaler - Product Status
Table 13: g60 Dry Powder Inhaler - Product Description
Table 14: Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 15: resQhaler - Product Status
Table 16: resQhaler - Product Description
Table 17: AKELA Pharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Fentanyl TAIFUN Inhaler - Product Status
Table 19: Fentanyl TAIFUN Inhaler - Product Description
Table 20: AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Duaklir Genuair Metered Dose Inhaler - Product Status
Table 22: Duaklir Genuair Metered Dose Inhaler - Product Description
Table 23: Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Ciprofloxacin Dry Powder Inhaler - Product Status
Table 25: Ciprofloxacin Dry Powder Inhaler - Product Description
Table 26: Boehringer Ingelheim International GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Next Generation Respimat Inhaler - Product Status
Table 28: Next Generation Respimat Inhaler - Product Description
Table 29: Circassia Group Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Tiotropium bromide DPI - Product Status
Table 31: Tiotropium bromide DPI - Product Description
Table 32: Creare LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Intranasal Dry Powder Inhaler - Product Status
Table 34: Intranasal Dry Powder Inhaler - Product Description
Table 35: Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Nasal Glucagon Delivery System - Product Status
Table 37: Nasal Glucagon Delivery System - Product Description
Table 38: GlaxoSmithKline Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Gemini Multi-Dose Combination Inhaler - Product Status
Table 40: Gemini Multi-Dose Combination Inhaler - Product Description
Table 41: Hovione Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Papillon DPI - Product Status
Table 43: Papillon DPI - Product Description

List of Figures
Figure 1: Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
Figure 2: Dry Powder Inhaler Devices - Pipeline Products by Territory
Figure 3: Dry Powder Inhaler Devices - Pipeline Products by Regulatory Path
Figure 4: Dry Powder Inhaler Devices - Pipeline Products by Estimated Approval Date
Figure 5: Dry Powder Inhaler Devices - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
  • Adamis Pharmaceuticals Corp
  • Advent Pharmaceuticals Pty Ltd
  • Aespira Ltd.
  • AKELA Pharma Inc. (Inactive)
  • AstraZeneca Plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Circassia Group Plc
  • Creare LLC
  • Eli Lilly and Co
  • GlaxoSmithKline Plc
  • Hovione Technology Ltd
  • Iconovo AB
  • Liquidia Technologies Inc
  • Lupin Pharmaceuticals Inc
  • MannKind Corp
  • Monash University
  • Nektar Therapeutics
  • Ology Bioservices Inc
  • OPKO Health Inc
  • OtiTopic LLC
  • Pharmaxis Ltd
  • Quench Medical Inc
  • Respira Therapeutics Inc
  • Sandoz International GmbH
  • Sheffield Hallam University
  • Spyryx Biosciences Inc
  • Sun Pharma Advanced Research Company Ltd
  • University of Kansas
  • University of Sydney
  • University of Texas Medical Branch at Galveston
  • Vectura Group Plc
  • Verona Pharma Plc
  • Virginia Commonwealth University
Note: Product cover images may vary from those shown
Adroll
adroll